右美托咪定在急诊科用于控制甲基苯丙胺所致躁动
本文报告两例急诊科甲基苯丙胺所致躁动患者。第一例42岁男性吸烟后情绪不稳、暴力行为,48小时内累计使用地西泮10mg与咪达唑仑332mg仍未控制躁动,改用右美托咪定后达到镇静。第二例38岁男性反复躁动,多次苯二氮䓬类剂量后仍发作,右美托咪定输注后躁动得到控制。两例中右美托咪定似乎减少了达到充分镇静所需的苯二氮䓬类剂量,并观察到一过性血压下降和心率减慢,自行缓解或减量后缓解,无需药物治疗。作者结论认为标准治疗失败时可考虑右美托咪定作为辅助化学约束,但给药期间应密切监测血流动力学,其在急诊科的有效性与安全性需前瞻性对照试验进一步评估。
要点
- 两例甲基苯丙胺所致躁动患者在苯二氮䓬类大量或反复给药后仍未控制,改用右美托咪定后镇静成功。
- 第一例48小时内累计使用地西泮10mg与咪达唑仑332mg仍未控制躁动,右美托咪定达到镇静。
- 两例中右美托咪定似乎减少了达到充分镇静所需的苯二氮䓬类剂量。
- 观察到一过性血压下降和心率减慢,自行缓解或减量后缓解,无需药物治疗。
- 作者认为标准治疗失败时可考虑右美托咪定作为辅助化学约束,但给药期间应密切监测血流动力学。
适用人群与场景
- 急诊科甲基苯丙胺所致躁动患者,标准苯二氮䓬类治疗未能控制躁动时
处置流程与药物剂量
- 第一例:48小时内累计使用地西泮10mg与咪达唑仑332mg仍未控制躁动后,使用右美托咪定达到镇静。
- 第二例:多次苯二氮䓬类剂量后仍反复躁动,使用右美托咪定输注后躁动得到控制。
- 给药期间应密切监测血流动力学,观察到一过性血压下降和心率减慢时可自行缓解或减量后缓解,无需药物治疗。
红旗征与不能漏的情况
- 右美托咪定给药期间出现一过性血压下降和心率减慢,需密切监测血流动力学。
研究设计与关键结果
- 病例报告:两例急诊科甲基苯丙胺所致躁动患者,第一例42岁男性吸烟后情绪不稳、暴力行为,48小时内累计使用地西泮10mg与咪达唑仑332mg未控制躁动,右美托咪定达到镇静;第二例38岁男性反复躁动,多次苯二氮䓬类剂量后仍发作,右美托咪定输注后躁动得到控制。
- 两例中右美托咪定似乎减少了达到充分镇静所需的苯二氮䓬类剂量,观察到一过性血压下降和心率减慢,自行缓解或减量后缓解,无需药物治疗。
证据类型、等级与局限
- 证据类型:病例报告(两例)。
- 作者结论:右美托咪定可考虑作为标准治疗失败时的辅助化学约束,但给药期间应密切监测血流动力学,其在急诊科的有效性与安全性需前瞻性对照试验进一步评估。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为当标准治疗(苯二氮䓬类)失败未能控制甲基苯丙胺所致躁动时,可考虑右美托咪定作为辅助化学约束。
- 给药期间应密切监测血流动力学,一过性血压下降和心率减慢可自行缓解或减量后缓解,无需药物治疗。
- 作者指出右美托咪定在急诊科的有效性与安全性需前瞻性对照试验进一步评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Chemical restraint is often required to control agitation induced by methamphetamine. Dexmedetomidine is an α-2 adrenergic receptor agonist with sedative, analgesic, and sympatholytic properties. Its use in the emergency department (ED) to control methamphetamine-induced agitation has not been reported.
OBJECTIVE: To report two cases of methamphetamine-induced agitation successfully sedated with dexmedetomidine in the ED.
CASE REPORT: The first case was a 42-year-old man with unstable emotion and violent behaviours after smoking methamphetamine. His agitation did not respond to a large cumulative dose of benzodiazepines (10mg of diazepam and 332mg of midazolam) administered over 48h and sedation was achieved with dexmedetomidine. The second case was a 38-year-old methamphetamine user with unstable emotion and recurrent episodes of agitation despite repeated doses of benzodiazepines, whose agitation was controlled with dexmedetomidine infusion.
DISCUSSION: In both cases, dexmedetomidine apparently reduced the dose of benzodiazepines needed to achieve adequate sedation. Transient falls in blood pressure and slowing of the heart rate were noted, which resolved either spontaneously or after reducing the infusion rate without requiring drug treatment.
CONCLUSION: Dexmedetomidine can be considered as an adjunct for chemical restraint when standard treatment fails to control the agitation induced by methamphetamine, but patient's hemodynamic state should be monitored closely during administration. Its efficacy and safety in the ED warrant further evaluation with prospective controlled trials.
参考来源
- Lam RPK, Yip WL, Wan CK, et al. Dexmedetomidine use in the ED for control of methamphetamine-induced agitation. Am J Emerg Med. 2016. PMID: 27842924. doi:10.1016/j.ajem.2016.11.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。